PLRX - Looking for a push off of $18
Most recent news from 2 days ago - finance.yahoo.com/news/pliant-therapeutics-receives-fda-fast-120000273.html
Technical look out:
- Looking for MACD to bounce up as it diverges
- RSI cooling off from the overbought zone so we can potentially expect some volume soon
- Price although has shown bear candles on the daily, it has consolidated fairly well considering the last spike from the news of --> finance.yahoo.com/news/pliant-therapeutics-inc-plrx-stock-083508031.html
Price action:
- Trading and consolidating within the July 14th candle. My price support is based off of this candle and a bounce up or break below it will dictate whether an entry takes place or not.
- If a proper bounce occurs I can see a conservative 5% within my radar or stretch to 15% on the top end. As per usual my trading strategy is to scale and secure profits so if momentum persist, I will hold past the 15% marker.
More news could help this one out in the coming weeks with earnings also only a few weeks away
Technical look out:
- Looking for MACD to bounce up as it diverges
- RSI cooling off from the overbought zone so we can potentially expect some volume soon
- Price although has shown bear candles on the daily, it has consolidated fairly well considering the last spike from the news of --> finance.yahoo.com/news/pliant-therapeutics-inc-plrx-stock-083508031.html
Price action:
- Trading and consolidating within the July 14th candle. My price support is based off of this candle and a bounce up or break below it will dictate whether an entry takes place or not.
- If a proper bounce occurs I can see a conservative 5% within my radar or stretch to 15% on the top end. As per usual my trading strategy is to scale and secure profits so if momentum persist, I will hold past the 15% marker.
More news could help this one out in the coming weeks with earnings also only a few weeks away
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.